ScoreWhy is Fusion Antibodies Plc ?
1
Flat results in Sep 25
- INTEREST(HY) At GBP 0.01 MM has Grown at 400%
- ROCE(HY) Lowest at -164.37%
- DEBT-EQUITY RATIO (HY) Highest at 18.73 %
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 87.50%, its profits have risen by 9.8%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Fusion Antibodies Plc for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Fusion Antibodies Plc
79.69%
3.33
77.51%
FTSE 100
13.98%
1.15
13.60%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-16.95%
EBIT Growth (5y)
-28.23%
EBIT to Interest (avg)
-1.84
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
1.42
Tax Ratio
2.05%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
15.91
EV to EBIT
-8.32
EV to EBITDA
-8.82
EV to Capital Employed
15.76
EV to Sales
9.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-189.50%
ROE (Latest)
-146.70%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -153.19% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 5.38 times
PRE-TAX PROFIT(Q)
Highest at GBP -0.55 MM
NET PROFIT(Q)
Highest at GBP -0.51 MM
EPS(Q)
Highest at GBP -0
-7What is not working for the Company
INTEREST(HY)
At GBP 0.01 MM has Grown at 400%
ROCE(HY)
Lowest at -164.37%
DEBT-EQUITY RATIO
(HY)
Highest at 18.73 %
Here's what is working for Fusion Antibodies Plc
Pre-Tax Profit
Highest at GBP -0.55 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (GBP MM)
Net Profit
Highest at GBP -0.51 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (GBP MM)
EPS
Highest at GBP -0
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (GBP)
Inventory Turnover Ratio
Highest at 5.38 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -153.19% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Fusion Antibodies Plc
Interest
At GBP 0.01 MM has Grown at 400%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (GBP MM)
Debt-Equity Ratio
Highest at 18.73 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
